[The competence network for congenital heart defects. Networking instead of isolated efforts for optimized research

Ulrike Bauer1, Eva Niggemeyer, Peter E Lange

  • 1Kompetenznetz Angeborene Herzfehler und Nationales Register für Angeborene Herzfehler E.v., Augustenburger Platz 1, 13353 Berlin. ahf@kompetenznetz-ahf.de

Medizinische Klinik (Munich, Germany : 1983)
|September 16, 2006
PubMed

Insights

The Competence Network for Congenital Heart Defects (CHD) improves care for patients with these common heart conditions. Data from the National Register informs research and develops better strategies for lifelong, multidisciplinary support.

Area of Science:

  • Cardiology
  • Public Health
  • Medical Informatics

Context:

  • Congenital heart defects (CHD) are the most common congenital malformations, affecting individuals throughout their lives.
  • Medical advancements have increased survival rates into adulthood, necessitating specialized lifelong care.
  • Existing care models require optimization through enhanced cooperation and research.

Purpose:

  • To establish nationwide cooperation and interdisciplinary research for congenital heart defect care.
  • To collect comprehensive data via the National Register for congenital heart defects.
  • To facilitate clinical studies on manifestations, diagnostics, and treatments.

Summary:

  • The Competence Network for Congenital Heart Defects, centered around the National Register, collects data on all CHD patients in Germany.
  • This data supports epidemiological studies on quality of life and psychosocial aspects.
  • The network aims to develop evidence-based pediatric guidelines and assess the current landscape of cardiac malformations.

Impact:

  • Enables integrated care and efficient knowledge transfer between science and practice.
  • Informs the development of S2-level pediatric guidelines for CHD.
  • Provides a foundation for evaluating CHD prevalence, adult patient needs, and future integrated healthcare databases.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...